{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:40:54Z","timestamp":1778611254607,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41390-021-01756-4","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T11:09:58Z","timestamp":1632913798000},"page":"867-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors"],"prefix":"10.1038","volume":"91","author":[{"given":"Ludmila N.","family":"Bakhireva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydan","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Hund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malia","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Salisbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"1756_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M17-0611","volume":"168","author":"E Krebs","year":"2018","unstructured":"Krebs, E. et al. Cost-effectiveness of publicly funded treatment of opioid use disorder in California. Ann. Intern. Med. 168, 10\u201319 (2018).","journal-title":"Ann. Intern. Med."},{"key":"1756_CR2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6928a1","volume":"69","author":"JY Ko","year":"2020","unstructured":"Ko, J. Y. et al. Vital signs: prescription opioid pain reliever use during pregnancy\u201434 U.S. jurisdictions, 2019. Morb. Mortal. Wkly Rep. 69, 897\u2013903 (2020).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"1756_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","volume":"123","author":"RJ Desai","year":"2014","unstructured":"Desai, R. J., Hernandez-Diaz, S., Bateman, B. T. & Huybrechts, K. F. Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstet. Gynecol. 123, 997\u20131002 (2014).","journal-title":"Obstet. Gynecol."},{"key":"1756_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1542\/peds.2014-3299","volume":"135","author":"SW Patrick","year":"2015","unstructured":"Patrick, S. W. et al. Prescription opioid epidemic and infant outcomes. Pediatrics 135, 842\u2013850 (2015).","journal-title":"Pediatrics"},{"key":"1756_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","volume":"67","author":"SC Haight","year":"2018","unstructured":"Haight, S. C., Ko, J. Y., Tong, V. T., Bohm, M. K. & Callaghan, W. M. Opioid use disorder documented at delivery hospitalization\u2014United States, 1999-2014. Morb. Mortal. Wkly Rep. 67, 845\u2013849 (2018).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"1756_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/1535370219851109","volume":"244","author":"NP Mortensen","year":"2019","unstructured":"Mortensen, N. P., Caffaro, M. M., Snyder, R. W., Yueh, Y. L. & Fennell, T. R. Placental trophoblast transfer of opioids following exposures to individual or mixtures of opioids in vitro. Exp. Biol. Med. (Maywood) 244, 846\u2013849 (2019).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"1756_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bcp.2004.09.008","volume":"69","author":"IA Nekhayeva","year":"2005","unstructured":"Nekhayeva, I. A. et al. Bidirectional transfer of methadone across human placenta. Biochem. Pharmacol. 69, 187\u2013197 (2005).","journal-title":"Biochem. Pharmacol."},{"key":"1756_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pcl.2018.12.006","volume":"66","author":"LM Jansson","year":"2019","unstructured":"Jansson, L. M. & Patrick, S. W. Neonatal abstinence syndrome. Pediatr. Clin. North. Am. 66, 353\u2013367 (2019).","journal-title":"Pediatr. Clin. North. Am."},{"key":"1756_CR9","first-page":"936","volume":"81","author":"TM Doberczak","year":"1993","unstructured":"Doberczak, T. M., Kandall, S. R. & Friedmann, P. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet. Gynecol. 81, 936\u2013940 (1993).","journal-title":"Obstet. Gynecol."},{"key":"1756_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/adc.2003.036863","volume":"89","author":"CA Kuschel","year":"2004","unstructured":"Kuschel, C. A., Austerberry, L., Cornwell, M., Couch, R. & Rowley, R. S. Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome? Arch. Dis. Child Fetal Neonatal Ed. 89, 390\u2013393 (2004).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"1756_CR11","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2012.3951","volume":"307","author":"SW Patrick","year":"2012","unstructured":"Patrick, S. W. et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 307, 1934\u20131940 (2012).","journal-title":"JAMA"},{"key":"1756_CR12","doi-asserted-by":"publisher","first-page":"e20173520","DOI":"10.1542\/peds.2017-3520","volume":"141","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman, T. N. A., Villapiano, N., Kozhimannil, K. B., Davis, M. M. & Patrick, S. W. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014. Pediatrics 141, e20173520 (2018).","journal-title":"Pediatrics"},{"key":"1756_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5055\/jom.2009.0006","volume":"5","author":"LM Jansson","year":"2009","unstructured":"Jansson, L. M., Velez, M., & Harrow, C. The opioid-exposed newborn: assessment and pharmacologic management. J. Opioid Manag. 5, 47\u201355 (2009).","journal-title":"J. Opioid Manag."},{"key":"1756_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1940-0640-9-19","volume":"9","author":"SM Bagley","year":"2014","unstructured":"Bagley, S. M., Wachman, E. M., Holland, E. & Brogly, S. B. Review of the assessment and management of neonatal abstinence syndrome. Addict. Sci. Clin. Pract. 9, 19 (2014).","journal-title":"Addict. Sci. Clin. Pract."},{"key":"1756_CR15","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1136\/bmj.j3326","volume":"358","author":"KF Huybrechts","year":"2017","unstructured":"Huybrechts, K. F. et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ 358, 3326 (2017).","journal-title":"BMJ"},{"key":"1756_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1360-0443.2012.04038.x","volume":"107","author":"K Kaltenbach","year":"2012","unstructured":"Kaltenbach, K. et al. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction 107, 45\u201352 (2012).","journal-title":"Addiction"},{"key":"1756_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1542\/hpeds.2016-0218","volume":"7","author":"MK Charles","year":"2017","unstructured":"Charles, M. K. et al. Male sex associated with increased risk of neonatal abstinence syndrome. Hosp. Pediatr. 7, 328\u2013334 (2017).","journal-title":"Hosp. Pediatr."},{"key":"1756_CR18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/AOG.0b013e31816fd910","volume":"111","author":"ACOG.","year":"2008","unstructured":"ACOG. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists Number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet. Gynecol. 111, 1001\u20131020 (2008).","journal-title":"Obstet. Gynecol."},{"key":"1756_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jad.2019.12.014","volume":"264","author":"NM Molenaar","year":"2020","unstructured":"Molenaar, N. M. et al. The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J. Affect. Disord. 264, 82\u201389 (2020).","journal-title":"J. Affect. Disord."},{"key":"1756_CR20","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","volume":"293","author":"EL Moses-Kolko","year":"2005","unstructured":"Moses-Kolko, E. L. et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293, 2372\u20132383 (2005).","journal-title":"JAMA"},{"key":"1756_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","volume":"173","author":"AL Salisbury","year":"2016","unstructured":"Salisbury, A. L. et al. The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month. Am. J. Psychiatry 173, 147\u2013157 (2016).","journal-title":"Am. J. Psychiatry"},{"key":"1756_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2125.2011.04072.x","volume":"73","author":"PGJ ter Horst","year":"2012","unstructured":"ter Horst, P. G. J. et al. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br. J. Clin. Pharm. 73, 295\u2013302 (2012).","journal-title":"J. Clin. Pharm."},{"key":"1756_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1203\/01.PDR.0000136278.23672.A0","volume":"56","author":"GM Anderson","year":"2004","unstructured":"Anderson, G. M., Czarkowski, K., Ravski, N. & Epperson, C. N. Platelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors. Pediatr. Res. 56, 418\u2013422 (2004).","journal-title":"Pediatr. Res."},{"key":"1756_CR24","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","volume":"60","author":"K Laine","year":"2003","unstructured":"Laine, K., Heikkinen, T., Ekblad, U. & Kero, P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch. Gen. Psychiatry 60, 720\u2013726 (2003).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1756_CR25","first-page":"e20150428","volume":"2","author":"LN Bakhireva","year":"2015","unstructured":"Bakhireva, L. N., Lowe, J. R., Gutierrez, H. L. & Stephen, J. M. Ethanol, Neurodevelopment, Infant and Child Health (ENRICH) prospective cohort: study design considerations. Adv. Pediatr. Res. 2, e20150428 (2015).","journal-title":"Adv. Pediatr. Res."},{"key":"1756_CR26","first-page":"141","volume":"2","author":"LP Finnegan","year":"1975","unstructured":"Finnegan, L. P., Connaughton, J. F. Jr., Kron, R. E. & Em-ich, J. P. Neonatal abstinence syndrome: assessment and management. Addict. Dis. 2, 141\u2013158 (1975).","journal-title":"Addict. Dis."},{"key":"1756_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3109\/14767058.2010.536863","volume":"24","author":"LM Leeman","year":"2011","unstructured":"Leeman, L. M. et al. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates. J. Matern. Fetal Neonatal Med. 24, 955\u2013959 (2011).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1756_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/bja\/aet153","volume":"111","author":"M Al-Hashimi","year":"2013","unstructured":"Al-Hashimi, M., Scott, S. W., Thompson, J. P. & Lambert, D. G. Opioids and immune modulation: more questions than answers. Br. J. Anaesth. 111, 80\u201388 (2013).","journal-title":"Br. J. Anaesth."},{"key":"1756_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ogc.2014.02.004","volume":"41","author":"S Gopman","year":"2014","unstructured":"Gopman, S. Prenatal and postpartum care of women with substance use disorders. Obstet. Gynecol. Clin. North. Am. 41, 213\u2013228 (2014).","journal-title":"Obstet. Gynecol. Clin. North. Am."},{"key":"1756_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3109\/14767058.2015.1018168","volume":"29","author":"C Kreitinger","year":"2016","unstructured":"Kreitinger, C. et al. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment. J. Matern. Fetal Neonatal Med. 29, 783\u2013788 (2016).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1756_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drugalcdep.2017.11.030","volume":"185","author":"K Kaltenbach","year":"2018","unstructured":"Kaltenbach, K. et al. Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes. Drug Alcohol Depend. 185, 40\u201349 (2018).","journal-title":"Drug Alcohol Depend."},{"key":"1756_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1542\/peds.109.5.815","volume":"109","author":"SW Jacobson","year":"2002","unstructured":"Jacobson, S. W., Chiodo, L. M., Sokol, R. J. & Jacobson, J. L. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome. Pediatrics 109, 815\u2013825 (2002).","journal-title":"Pediatrics"},{"key":"1756_CR33","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.15288\/jsa.1975.36.1154","volume":"36","author":"RS Bowman","year":"1975","unstructured":"Bowman, R. S., Stein, L. I. & Newton, J. R. Measurement and interpretation of drinking behavior: I. On measuring patterns of alcohol consumption: II. Relationships between drinking behavior and social adjustment in a sample of problem drinkers. J. Stud. Alcohol. 36, 1154\u20131172 (1975).","journal-title":"J. Stud. Alcohol."},{"key":"1756_CR34","doi-asserted-by":"publisher","unstructured":"United States Department of Health Human Services: Substance Abuse Mental Health Services Administration, Center for Behavioral Health Statistics Quality. National Survey on Drug Use and Health, 2011, v. 2015. https:\/\/doi.org\/10.3886\/ICPSR34481.v4.","DOI":"10.3886\/ICPSR34481.v4"},{"key":"1756_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/EDE.0b013e31823aca5d","volume":"23","author":"TJ VanderWeele","year":"2012","unstructured":"VanderWeele, T. J., Mumford, S. L. & Schisterman, E. F. Conditioning on intermediates in perinatal epidemiology. Epidemiology 23, 1\u20139 (2012).","journal-title":"Epidemiology"},{"key":"1756_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/ADM.0000000000000484","volume":"13","author":"V Bhatt-Mehta","year":"2019","unstructured":"Bhatt-Mehta, V., Richards, J., Sturza, J. & Schumacher, R. E. Impact of in-utero exposure to selective serotonin reuptake inhibitors and opioids on neonatal opioid withdrawal syndrome. J. Addict. Med. 13, 227\u2013234 (2019).","journal-title":"J. Addict. Med."},{"key":"1756_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajog.2008.06.088","volume":"199","author":"NS Seligman","year":"2008","unstructured":"Seligman, N. S. et al. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am. J. Obstet. Gynecol. 199, 1\u20137 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1756_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/ADM.0b013e3182266a3a","volume":"5","author":"EM Wachman","year":"2011","unstructured":"Wachman, E. M. et al. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome. J. Addict. Med. 5, 293\u2013299 (2011).","journal-title":"J. Addict. Med."},{"key":"1756_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3109\/14767058.2014.987750","volume":"29","author":"AB O\u2019Connor","year":"2016","unstructured":"O\u2019Connor, A. B., O\u2019Brien, L., Alto, W. A. & Wong, J. Does concurrent in utero exposure to buprenorphine and antidepressant medications influence the course of neonatal abstinence syndrome? J. Matern. Fetal Neonatal Med. 29, 112\u2013114 (2016).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"1756_CR40","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","volume":"363","author":"HE Jones","year":"2010","unstructured":"Jones, H. E. et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N. Engl. J. Med. 363, 2320\u20132331 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1756_CR41","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00204-018-2244-6","volume":"92","author":"BA Baldo","year":"2018","unstructured":"Baldo, B. A. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Arch. Toxicol. 92, 2457\u20132473 (2018).","journal-title":"Arch. Toxicol."},{"key":"1756_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1389200023338017","volume":"3","author":"A Hemeryck","year":"2002","unstructured":"Hemeryck, A. & Belpaire, F. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr. Drug Metab. 3, 13\u201337 (2002).","journal-title":"Curr. Drug Metab."},{"key":"1756_CR43","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/pch\/16.9.562","volume":"16","author":"AL Jefferies","year":"2011","unstructured":"Jefferies, A. L. Selective serotonin reuptake inhibitors in pregnancy and infant outcomes. Paediatr. Child Health 16, 562\u2013563 (2011).","journal-title":"Paediatr. Child Health"},{"key":"1756_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","volume":"197","author":"CM Jones","year":"2019","unstructured":"Jones, C. M. & McCance-Katz, E. F. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 197, 78\u201382 (2019).","journal-title":"Drug Alcohol Depend."},{"key":"1756_CR45","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/aje\/kwr230","volume":"174","author":"AJ Wilcox","year":"2011","unstructured":"Wilcox, A. J., Weinberg, C. R. & Basso, O. On the pitfalls of adjusting for gestational age at birth. Am. J. Epidemiol. 174, 1062\u20131068 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"1756_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ajog.2017.04.016","volume":"217","author":"CV Ananth","year":"2017","unstructured":"Ananth, C. V. & Schisterman, E. F. Confounding, causality, and confusion: the role of intermediate variables in interpreting observational studies in obstetrics. Am. J. Obstet. Gynecol. 217, 167\u2013175 (2017).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1756_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40429-017-0132-4","volume":"4","author":"CL Arnaudo","year":"2017","unstructured":"Arnaudo, C. L., Andraka-Christou, B. & Allgood, K. Psychiatric co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment. Curr. Addict. Rep. 4, 1\u201313 (2017).","journal-title":"Curr. Addict. Rep."},{"key":"1756_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/AOG.0000000000002235","volume":"130","author":"ACOG.","year":"2017","unstructured":"ACOG. Committee Opinion No. 711: Opioid use and opioid use disorder in pregnancy. Obstet. Gynecol. 130, 81 (2017).","journal-title":"Obstet. Gynecol."},{"key":"1756_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0167482X.2020.1727882","volume":"18","author":"Y Shen","year":"2020","unstructured":"Shen, Y., Lo-Ciganic, W. H., Segal, R. & Goodin, A. J. Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009-2014. J. Psychosom. Obstet. Gynaecol. 18, 1\u20137 (2020).","journal-title":"J. Psychosom. Obstet. Gynaecol."},{"key":"1756_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.genhosppsych.2009.04.003","volume":"31","author":"K Yonkers","year":"2009","unstructured":"Yonkers, K. et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen. Hosp. Psychiatry 31, 403\u2013413 (2009).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"1756_CR51","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10995-020-02904-8","volume":"24","author":"CE Martin","year":"2020","unstructured":"Martin, C. E., Scialli, A. & Terplan, M. Addiction and depression: unmet treatment needs among reproductive age women. Matern. Child Health J. 24, 660\u2013667 (2020).","journal-title":"Matern. Child Health J."},{"key":"1756_CR52","doi-asserted-by":"publisher","first-page":"e106975","DOI":"10.1016\/j.ntt.2021.106975","volume":"86","author":"S Shrestha","year":"2021","unstructured":"Shrestha, S., Roberts, M. H., Maxwell, J. R., Leeman, L. M. & Bakhireva, L. N. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome. Neurotoxicol. Teratol. 86, e106975 (2021).","journal-title":"Neurotoxicol. Teratol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01756-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T06:05:04Z","timestamp":1666850704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01756-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01756-4","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}